Kate El Bouzidi1,2, Fati Murtala-Ibrahim3, Vivian Kwaghe4, Rawlings P Datir5, Obinna Ogbanufe6, Trevor A Crowell7,8, Man Charurat9, Patrick Dakum3, Ravindra K Gupta5,10, Nicaise Ndembi3,9,11, Caroline A Sabin2. 1. Division of Infection & Immunity, University College London, London, United Kingdom. 2. Institute for Global Health, University College London, London, United Kingdom. 3. Institute of Human Virology Nigeria, Abuja, Nigeria. 4. University of Abuja Teaching Hospital, Abuja, Nigeria. 5. Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom. 6. U.S. Centers for Disease Control and Prevention, U.S. Embassy, Abuja, Nigeria. 7. U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD. 8. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD. 9. Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD. 10. Africa Health Research Institute, Durban, South Africa; and. 11. Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.
Abstract
BACKGROUND: Understanding the correlates of disengagement from HIV care and treatment failure during second-line antiretroviral therapy (ART) could inform interventions to improve clinical outcomes among people living with HIV (PLHIV). METHODS: We conducted a retrospective cohort study of PLHIV aged >15 years who started second-line ART at a tertiary center in Nigeria between 2005 and 2017. Participants were considered to have disengaged from care if they had not returned within a year after each clinic visit. Cox proportional hazard models were used to investigate factors associated with: (1) viral failure (HIV-1 RNA >1000 copies/mL), (2) immunologic failure (CD4 count decrease or <100 cells/mm3), and (3) severe weight loss (>10% of bodyweight), after >6 months of second-line ART. RESULTS: Among 1031 participants, 33% (341) disengaged from care during a median follow-up of 6.9 years (interquartile range 3.7-8.5). Of these, 26% (89/341) subsequently reentered care. Disengagement was associated with male gender, age <30 years, lower education level, and low CD4 count at second-line ART initiation. Among participants with endpoint assessments available, 20% (112/565) experienced viral failure, 32% (257/809) experienced immunologic failure, and 23% (190/831) experienced weight loss. A lower risk of viral failure was associated with professional occupations compared with elementary: adjusted hazard ratio 0.17 (95% confidence interval 0.04 to 0.70). CONCLUSION: Adverse outcomes were common during second-line ART. However, reengagement is possible and resources should be allocated to focus on retaining PLHIV in care and providing services to trace and reengage those who have disengaged from care.
BACKGROUND: Understanding the correlates of disengagement from HIV care and treatment failure during second-line antiretroviral therapy (ART) could inform interventions to improve clinical outcomes among people living with HIV (PLHIV). METHODS: We conducted a retrospective cohort study of PLHIV aged >15 years who started second-line ART at a tertiary center in Nigeria between 2005 and 2017. Participants were considered to have disengaged from care if they had not returned within a year after each clinic visit. Cox proportional hazard models were used to investigate factors associated with: (1) viral failure (HIV-1 RNA >1000 copies/mL), (2) immunologic failure (CD4 count decrease or <100 cells/mm3), and (3) severe weight loss (>10% of bodyweight), after >6 months of second-line ART. RESULTS: Among 1031 participants, 33% (341) disengaged from care during a median follow-up of 6.9 years (interquartile range 3.7-8.5). Of these, 26% (89/341) subsequently reentered care. Disengagement was associated with male gender, age <30 years, lower education level, and low CD4 count at second-line ART initiation. Among participants with endpoint assessments available, 20% (112/565) experienced viral failure, 32% (257/809) experienced immunologic failure, and 23% (190/831) experienced weight loss. A lower risk of viral failure was associated with professional occupations compared with elementary: adjusted hazard ratio 0.17 (95% confidence interval 0.04 to 0.70). CONCLUSION: Adverse outcomes were common during second-line ART. However, reengagement is possible and resources should be allocated to focus on retaining PLHIV in care and providing services to trace and reengage those who have disengaged from care.
Authors: Chinenye Ugoji; Nwanneka Okere; Patrick Dakum; Rukeme Ake-Uzoigwe; Donald Igboelina; Nicaise Ndembi; Ernest Ekong; Manhattan Charurat; William A Blattner Journal: Curr HIV Res Date: 2015 Impact factor: 1.581
Authors: Marianne A B van der Sande; Maarten F Schim van der Loeff; Akum A Aveika; Saihou Sabally; Toyin Togun; Ramu Sarge-Njie; Abraham S Alabi; Assan Jaye; Tumani Corrah; Hilton C Whittle Journal: J Acquir Immune Defic Syndr Date: 2004-10-01 Impact factor: 3.731
Authors: Hermann Bussmann; C William Wester; Ndwapi Ndwapi; Nicolas Grundmann; Tendani Gaolathe; John Puvimanasinghe; Ava Avalos; Madisa Mine; Khumo Seipone; Max Essex; Victor Degruttola; Richard G Marlink Journal: AIDS Date: 2008-11-12 Impact factor: 4.177
Authors: Kate El Bouzidi; Steven A Kemp; Rawlings P Datir; Fati Murtala-Ibrahim; Ahmad Aliyu; Vivian Kwaghe; Dan Frampton; Sunando Roy; Judith Breuer; Caroline A Sabin; Obinna Ogbanufe; Man E Charurat; David Bonsall; Tanya Golubchik; Christophe Fraser; Patrick Dakum; Nicaise Ndembi; Ravindra K Gupta Journal: J Antimicrob Chemother Date: 2020-06-01 Impact factor: 5.790
Authors: Nicaise Ndembi; Fati Murtala-Ibrahim; Monday Tola; Jibreel Jumare; Ahmad Aliyu; Peter Alabi; Charles Mensah; Alash'le Abimiku; Miguel E Quiñones-Mateu; Trevor A Crowell; Soo-Yon Rhee; Robert W Shafer; Ravindra Gupta; William Blattner; Manhattan E Charurat; Patrick Dakum Journal: AIDS Res Ther Date: 2020-11-03 Impact factor: 2.250